Table 1.
The immunological work-up of the patient
| Absolute value (%) | Reference range due to age (%) | |
|---|---|---|
| White blood cell count (cells/mm3) | 11,000 | 6000–17,500 |
| Total neutrophil count (cells/mm3) | 5870 (53.3) | 1500 to 8500 (15–45) |
| Total eosinophil count (cells/mm3) | 190 (1.7) | 180–510 (1–4) |
| Total lymphocyte count (cells/mm3) | 3700 (33) | 3000–10,000 (45–75) |
| Lymphocyte subsets (cells/mm3) | ||
| CD3 + CD16-56- | 2146 (58) | 2400–8100 (51–79) |
| CD3 + CD4+ | 296 (8) | 1400–5200 (31–54) |
| CD3 + CD8+ | 1517 (41) | 600–3000 (10–31) |
| CD3-CD16 + 56+ | 259 (7) | 200–1800 (5–23) |
| CD4 + 45RA+ | 15 (5) | 1200–5600 (25–45) |
| CD4 + 45RO+ | 12 (4) | 300–1400 (6–21) |
| CD19+ | 1258 (34) | 500–3600 (14–44) |
| HLA DR | 779 (62) | 200–3100 (15–48) |
| TCR γ/δ | 370 (10) | (< 5) |
| CD4 + CD45RA + CD31+ (RTE) | (44) | (> 50) |
| Lymphocyte proliferation tests | ||
|
Response to PHA CD3 + 25+ |
54% | 37–57% |
| CD3 + 69+ | 55% | 57–69% |
| Immunoglobulin levels | ||
| IgG (mg/dl) | 894 | 463–1006 |
| IgA (mg/dl) | 51 | 17–69 |
| IgM (mg/dl) | 61 | 46–159 |
| Total IgE (IU/ml) | 9 | < 15 |
| Serum antibody response | Anti-HBs positive | |
| Oxidative Burst Test | Normal (MFI:138) | |